Sumitomo Life Insurance Co. decreased its position in  Morgan Stanley (NYSE:MS – Free Report) by 5.9% during the 2nd quarter, Holdings Channel reports. The firm owned 20,803 shares of the financial services provider’s stock after selling 1,294 shares during the period. Sumitomo Life Insurance Co.’s holdings in Morgan Stanley were worth $2,930,000 at the end of the most recent quarter. 
Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Meadow Creek Wealth Advisors LLC lifted its stake in Morgan Stanley by 2.5% in the second quarter. Meadow Creek Wealth Advisors LLC now owns 2,799 shares of the financial services provider’s stock worth $394,000 after acquiring an additional 69 shares during the period. Gallagher Capital Advisors LLC lifted its stake in Morgan Stanley by 0.7% in the second quarter. Gallagher Capital Advisors LLC now owns 9,969 shares of the financial services provider’s stock worth $1,420,000 after acquiring an additional 70 shares during the period. McLean Asset Management Corp lifted its stake in Morgan Stanley by 2.5% in the second quarter. McLean Asset Management Corp now owns 3,007 shares of the financial services provider’s stock worth $430,000 after acquiring an additional 73 shares during the period. Pinnacle Bancorp Inc. lifted its stake in Morgan Stanley by 1.5% in the second quarter. Pinnacle Bancorp Inc. now owns 5,022 shares of the financial services provider’s stock worth $707,000 after acquiring an additional 75 shares during the period. Finally, Congress Park Capital LLC lifted its stake in Morgan Stanley by 2.4% in the second quarter. Congress Park Capital LLC now owns 3,250 shares of the financial services provider’s stock worth $458,000 after acquiring an additional 75 shares during the period. Institutional investors own 84.19% of the company’s stock.
Insider Buying and Selling at Morgan Stanley
In other news, CEO Edward Pick sold 100,000 shares of the firm’s stock in a transaction on Friday, October 31st. The stock was sold at an average price of $164.34, for a total transaction of $16,434,000.00. Following the completion of the transaction, the chief executive officer directly owned 574,986 shares in the company, valued at $94,493,199.24. This trade represents a 14.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.19% of the stock is owned by insiders.
Morgan Stanley Stock Performance
Morgan Stanley (NYSE:MS – Get Free Report) last announced its quarterly earnings data on Wednesday, October 15th. The financial services provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.07 by $0.73. The business had revenue of $18.22 billion during the quarter, compared to analyst estimates of $16.42 billion. Morgan Stanley had a return on equity of 16.55% and a net margin of 13.85%.The company’s revenue for the quarter was up 18.5% on a year-over-year basis. During the same quarter last year, the firm posted $1.88 earnings per share. On average, equities analysts forecast that Morgan Stanley will post 8.56 earnings per share for the current fiscal year.
Morgan Stanley Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 31st will be given a dividend of $1.00 per share. The ex-dividend date of this dividend is Friday, October 31st. This represents a $4.00 annualized dividend and a yield of 2.4%. Morgan Stanley’s dividend payout ratio (DPR) is currently 41.03%.
Analyst Upgrades and Downgrades
A number of analysts recently commented on the company. Citigroup raised their price target on Morgan Stanley from $155.00 to $170.00 and gave the stock a “neutral” rating in a research note on Thursday, October 16th. Zacks Research raised Morgan Stanley from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 21st. Jefferies Financial Group raised their price target on Morgan Stanley from $175.00 to $186.00 and gave the stock a “buy” rating in a research note on Thursday, October 16th. The Goldman Sachs Group raised their price target on Morgan Stanley from $145.00 to $164.00 and gave the stock a “neutral” rating in a research note on Friday, October 3rd. Finally, Wells Fargo & Company raised their price target on Morgan Stanley from $165.00 to $177.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 16th. Three investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $168.23.
Check Out Our Latest Report on Morgan Stanley
Morgan Stanley Profile
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Further Reading
- Five stocks we like better than Morgan Stanley
 - 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
 - Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No
 - What Are Dividend Contenders? Investing in Dividend Contenders
 - ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
 - 3 Small Caps With Big Return Potential
 - Super Micro’s Moment of Truth: A Growth Story Under Pressure
 
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.
